The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.
June 13, 2023 at 12:59AM
from Times of India
https://ift.tt/0PQkGZ1
Phase-3 trials find 1-shot chikungunya vaccine safe: Lancet
Subscribe to:
Post Comments (Atom)
It’s not just alcohol! 6 common habits are damaging your liver too
Many daily habits silently harm the liver. Excessive sugar intake causes fatty liver. Overusing painkillers strains liver function. Sedentar...
-
Several notable WWE veterans passed away in 2024, including Sika Anoa'i, Francisco Ciatso, Akebono, Ole Anderson, and Virgil. These wres...
-
Supreme Court on Tuesday rejected pleas for a retest for admissions to 1.08 lakh MBBS seats in govt and private medical colleges in the abse...
-
Horoscope Today: Read daily horoscope predictions for December 7, 2024. Know all about the astrological events and influences that will be a...
No comments:
Post a Comment